186 related articles for article (PubMed ID: 14607962)
21. RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis.
Pettit AR; Walsh NC; Manning C; Goldring SR; Gravallese EM
Rheumatology (Oxford); 2006 Sep; 45(9):1068-76. PubMed ID: 16490750
[TBL] [Abstract][Full Text] [Related]
22. miR-145-5p Increases Osteoclast Numbers In Vitro and Aggravates Bone Erosion in Collagen-Induced Arthritis by Targeting Osteoprotegerin.
Chen Y; Wang X; Yang M; Ruan W; Wei W; Gu D; Wang J; Guo X; Guo L; Yuan Y
Med Sci Monit; 2018 Jul; 24():5292-5300. PubMed ID: 30059491
[TBL] [Abstract][Full Text] [Related]
23. Receptor activator of nuclear factor-kappa b ligand activates nuclear factor-kappa b in osteoclast precursors.
Wei S; Teitelbaum SL; Wang MW; Ross FP
Endocrinology; 2001 Mar; 142(3):1290-5. PubMed ID: 11181547
[TBL] [Abstract][Full Text] [Related]
24. Curcumin (diferuloylmethane) inhibits receptor activator of NF-kappa B ligand-induced NF-kappa B activation in osteoclast precursors and suppresses osteoclastogenesis.
Bharti AC; Takada Y; Aggarwal BB
J Immunol; 2004 May; 172(10):5940-7. PubMed ID: 15128775
[TBL] [Abstract][Full Text] [Related]
25. GDF11 antagonizes TNF-α-induced inflammation and protects against the development of inflammatory arthritis in mice.
Li W; Wang W; Liu L; Qu R; Chen X; Qiu C; Li J; Hayball J; Liu L; Chen J; Wang X; Pan X; Zhao Y
FASEB J; 2019 Mar; 33(3):3317-3329. PubMed ID: 30407878
[TBL] [Abstract][Full Text] [Related]
26. I{kappa}B kinase (IKK){beta}, but not IKK{alpha}, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss.
Ruocco MG; Maeda S; Park JM; Lawrence T; Hsu LC; Cao Y; Schett G; Wagner EF; Karin M
J Exp Med; 2005 May; 201(10):1677-87. PubMed ID: 15897281
[TBL] [Abstract][Full Text] [Related]
27. RANK signaling is not required for TNFalpha-mediated increase in CD11(hi) osteoclast precursors but is essential for mature osteoclast formation in TNFalpha-mediated inflammatory arthritis.
Li P; Schwarz EM; O'Keefe RJ; Ma L; Boyce BF; Xing L
J Bone Miner Res; 2004 Feb; 19(2):207-13. PubMed ID: 14969390
[TBL] [Abstract][Full Text] [Related]
28. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.
Kim HJ; Chang EJ; Kim HM; Lee SB; Kim HD; Su Kim G; Kim HH
Free Radic Biol Med; 2006 May; 40(9):1483-93. PubMed ID: 16632109
[TBL] [Abstract][Full Text] [Related]
29. Acetyl-11-keto-beta-boswellic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing NF-kappa B and NF-kappa B-regulated gene expression.
Takada Y; Ichikawa H; Badmaev V; Aggarwal BB
J Immunol; 2006 Mar; 176(5):3127-40. PubMed ID: 16493072
[TBL] [Abstract][Full Text] [Related]
30. N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of I(kappa)B(alpha) kinase and nuclear factor-kappaB-regulated gene products.
Shishodia S; Gutierrez AM; Lotan R; Aggarwal BB
Cancer Res; 2005 Oct; 65(20):9555-65. PubMed ID: 16230421
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.
Takatsuna H; Asagiri M; Kubota T; Oka K; Osada T; Sugiyama C; Saito H; Aoki K; Ohya K; Takayanagi H; Umezawa K
J Bone Miner Res; 2005 Apr; 20(4):653-62. PubMed ID: 15765185
[TBL] [Abstract][Full Text] [Related]
32. Enhanced osteoclast development in collagen-induced arthritis in interferon-gamma receptor knock-out mice as related to increased splenic CD11b+ myelopoiesis.
De Klerck B; Carpentier I; Lories RJ; Habraken Y; Piette J; Carmeliet G; Beyaert R; Billiau A; Matthys P
Arthritis Res Ther; 2004; 6(3):R220-31. PubMed ID: 15142268
[TBL] [Abstract][Full Text] [Related]
33. Bone destruction in arthritis.
Gravallese EM
Ann Rheum Dis; 2002 Nov; 61 Suppl 2(Suppl 2):ii84-6. PubMed ID: 12379632
[TBL] [Abstract][Full Text] [Related]
34. NF-kappaB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor.
Kubota T; Hoshino M; Aoki K; Ohya K; Komano Y; Nanki T; Miyasaka N; Umezawa K
Arthritis Res Ther; 2007; 9(5):R97. PubMed ID: 17892600
[TBL] [Abstract][Full Text] [Related]
35. Dynein light chain LC8 inhibits osteoclast differentiation and prevents bone loss in mice.
Kim H; Hyeon S; Kim H; Yang Y; Huh JY; Park DR; Lee H; Seo DH; Kim HS; Lee SY; Jeong W
J Immunol; 2013 Feb; 190(3):1312-8. PubMed ID: 23293355
[TBL] [Abstract][Full Text] [Related]
36. NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis.
Xing L; Bushnell TP; Carlson L; Tai Z; Tondravi M; Siebenlist U; Young F; Boyce BF
J Bone Miner Res; 2002 Jul; 17(7):1200-10. PubMed ID: 12096833
[TBL] [Abstract][Full Text] [Related]
37. The antirheumatic drug leflunomide inhibits osteoclastogenesis by interfering with receptor activator of NF-kappa B ligand-stimulated induction of nuclear factor of activated T cells c1.
Urushibara M; Takayanagi H; Koga T; Kim S; Isobe M; Morishita Y; Nakagawa T; Löeffler M; Kodama T; Kurosawa H; Taniguchi T
Arthritis Rheum; 2004 Mar; 50(3):794-804. PubMed ID: 15022321
[TBL] [Abstract][Full Text] [Related]
38. Pyrrolidine dithiocarbamate attenuates the development of acute and chronic inflammation.
Cuzzocrea S; Chatterjee PK; Mazzon E; Dugo L; Serraino I; Britti D; Mazzullo G; Caputi AP; Thiemermann C
Br J Pharmacol; 2002 Jan; 135(2):496-510. PubMed ID: 11815386
[TBL] [Abstract][Full Text] [Related]
39. Ligation of TLR5 promotes myeloid cell infiltration and differentiation into mature osteoclasts in rheumatoid arthritis and experimental arthritis.
Kim SJ; Chen Z; Chamberlain ND; Essani AB; Volin MV; Amin MA; Volkov S; Gravallese EM; Arami S; Swedler W; Lane NE; Mehta A; Sweiss N; Shahrara S
J Immunol; 2014 Oct; 193(8):3902-13. PubMed ID: 25200955
[TBL] [Abstract][Full Text] [Related]
40. Inflammatory osteolysis is regulated by site-specific ISGylation of the scaffold protein NEMO.
Adapala NS; Swarnkar G; Arra M; Shen J; Mbalaviele G; Ke K; Abu-Amer Y
Elife; 2020 Mar; 9():. PubMed ID: 32202502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
